96 related articles for article (PubMed ID: 24240683)
1. PRH/HHex inhibits the migration of breast and prostate epithelial cells through direct transcriptional regulation of Endoglin.
Kershaw RM; Siddiqui YH; Roberts D; Jayaraman PS; Gaston K
Oncogene; 2014 Dec; 33(49):5592-600. PubMed ID: 24240683
[TBL] [Abstract][Full Text] [Related]
2. Blood platelets stimulate cancer extravasation through TGFβ-mediated downregulation of PRH/HHEX.
Marcolino E; Siddiqui YH; van den Bosch M; Poole AW; Jayaraman PS; Gaston K
Oncogenesis; 2020 Feb; 9(2):10. PubMed ID: 32019914
[TBL] [Abstract][Full Text] [Related]
3. CK2 abrogates the inhibitory effects of PRH/HHEX on prostate cancer cell migration and invasion and acts through PRH to control cell proliferation.
Siddiqui YH; Kershaw RM; Humphreys EH; Assis Junior EM; Chaudhri S; Jayaraman PS; Gaston K
Oncogenesis; 2017 Jan; 6(1):e293. PubMed ID: 28134934
[TBL] [Abstract][Full Text] [Related]
4. Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion.
Gaston K; Tsitsilianos MA; Wadey K; Jayaraman PS
Cell Biosci; 2016; 6():12. PubMed ID: 26877867
[TBL] [Abstract][Full Text] [Related]
5. A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition.
Kitchen P; Lee KY; Clark D; Lau N; Lertsuwan J; Sawasdichai A; Satayavivad J; Oltean S; Afford S; Gaston K; Jayaraman PS
Cancer Res; 2020 Feb; 80(4):757-770. PubMed ID: 31843982
[TBL] [Abstract][Full Text] [Related]
6. Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration.
Romero D; Terzic A; Conley BA; Craft CS; Jovanovic B; Bergan RC; Vary CP
Carcinogenesis; 2010 Mar; 31(3):359-66. PubMed ID: 19736306
[TBL] [Abstract][Full Text] [Related]
7. Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion.
Liu Y; Jovanovic B; Pins M; Lee C; Bergan RC
Oncogene; 2002 Nov; 21(54):8272-81. PubMed ID: 12447690
[TBL] [Abstract][Full Text] [Related]
8. PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.
Noy P; Williams H; Sawasdichai A; Gaston K; Jayaraman PS
Mol Cell Biol; 2010 May; 30(9):2120-34. PubMed ID: 20176809
[TBL] [Abstract][Full Text] [Related]
9. Soluble MMP-14 produced by bone marrow-derived stromal cells sheds epithelial endoglin modulating the migratory properties of human breast cancer cells.
Tobar N; Avalos MC; Méndez N; Smith PC; Bernabeu C; Quintanilla M; Martínez J
Carcinogenesis; 2014 Aug; 35(8):1770-9. PubMed ID: 24618373
[TBL] [Abstract][Full Text] [Related]
10. Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells.
O'Connor JC; Farach-Carson MC; Schneider CJ; Carson DD
Mol Cancer Res; 2007 Jun; 5(6):585-603. PubMed ID: 17579118
[TBL] [Abstract][Full Text] [Related]
11. Hhex inhibits cell migration via regulating RHOA/CDC42-CFL1 axis in human lung cancer cells.
Li X; Ma G; Guo W; Mu N; Wang Y; Liu X; Su L
Cell Commun Signal; 2021 Jul; 19(1):80. PubMed ID: 34321041
[TBL] [Abstract][Full Text] [Related]
12. New Roles of Osteocytes in Proliferation, Migration and Invasion of Breast and Prostate Cancer Cells.
Cui YX; Evans BA; Jiang WG
Anticancer Res; 2016 Mar; 36(3):1193-201. PubMed ID: 26977015
[TBL] [Abstract][Full Text] [Related]
13. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome.
Henry LA; Johnson DA; Sarrió D; Lee S; Quinlan PR; Crook T; Thompson AM; Reis-Filho JS; Isacke CM
Oncogene; 2011 Mar; 30(9):1046-58. PubMed ID: 21042283
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
[TBL] [Abstract][Full Text] [Related]
15. Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype.
Oxmann D; Held-Feindt J; Stark AM; Hattermann K; Yoneda T; Mentlein R
Oncogene; 2008 Jun; 27(25):3567-75. PubMed ID: 18223685
[TBL] [Abstract][Full Text] [Related]
16. Proline-Rich Homeodomain protein (PRH/HHEX) is a suppressor of breast tumour growth.
Kershaw RM; Roberts D; Wragg J; Shaaban AM; Humphreys E; Halsall J; Price L; Bicknell R; Gaston K; Jayaraman PS
Oncogenesis; 2017 Jun; 6(6):e346. PubMed ID: 28604763
[TBL] [Abstract][Full Text] [Related]
17. Endoglin regulates cancer-stromal cell interactions in prostate tumors.
Romero D; O'Neill C; Terzic A; Contois L; Young K; Conley BA; Bergan RC; Brooks PC; Vary CP
Cancer Res; 2011 May; 71(10):3482-93. PubMed ID: 21444673
[TBL] [Abstract][Full Text] [Related]
18. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
19. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.
Gu X; Zerbini LF; Otu HH; Bhasin M; Yang Q; Joseph MG; Grall F; Onatunde T; Correa RG; Libermann TA
Cancer Res; 2007 May; 67(9):4219-26. PubMed ID: 17483333
[TBL] [Abstract][Full Text] [Related]
20. SLUG is a direct transcriptional repressor of PTEN tumor suppressor.
Uygur B; Abramo K; Leikina E; Vary C; Liaw L; Wu WS
Prostate; 2015 Jun; 75(9):907-16. PubMed ID: 25728608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
